Spaulding Clinical Research, LLC
West Bend, Wisconsin, 53095, United States
NCT Number: NCT02365532
This study will evaluate the effect of oral GS-6615 on QTc interval in healthy adults with dofetilide-induced QTc prolongation.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
West Bend, Wisconsin, 53095, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
GS-6615 tablets administered orally
Placebo to match GS-6615 tablets administered orally
Placebo to match dofetilide capsules administered orally
Dofetilide 500 μg capsules administered orally according to the current prescribing information
Time frame: Up to 6 days
Time frame: Predose and postdose on Days -2 through Day 4
This endpoint will measure the plasma PK profiles of GS-6615 and dofetilide. PK parameters that will be measured include Cmax, Tmax, AUC_0-24, and AUC_0-tlast.
Time frame: Up to 6 days
This endpoint will measure the safety and tolerability profile of GS-6615.
Gilead Sciences
Industry
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04712136
Aortic Stenosis, Subvalvular, Aortic Valve Disease
Montpellier, Occitanie, France
View Trial DetailsNCT04675788
Abnormalities, Drug-Induced, Arrhythmias, Cardiac
Indianapolis, Indiana, United States
View Trial DetailsNCT05274646
Arrhythmias, Cardiac, Brugada Syndrome
Saint-Pierre, France, Reunion
View Trial DetailsNCT05964322
Arrhythmias, Cardiac, Cardiac Conduction System Disease
Montpellier, France
View Trial Details